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AbstrAct
background Cystic fibrosis (CF) lung disease is 
defined by large numbers of neutrophils and associated 
damaging products in the airway. Delayed neutrophil 
apoptosis is described in CF although it is unclear 
whether this is a primary neutrophil defect or a response 
to chronic inflammation. Increased levels of neutrophil 
extracellular traps (NETs) have been measured in CF and 
we aimed to investigate the causal relationship between 
these phenomena and their potential to serve as a 
driver of inflammation. We hypothesised that the delay 
in apoptosis in CF is a primary defect and preferentially 
allows CF neutrophils to form NETs, contributing to 
inflammation.
Methods Blood neutrophils were isolated from patients 
with CF, CF pigs and appropriate controls. Neutrophils 
were also obtained from patients with CF before and 
after commencing ivacaftor. Apoptosis was assessed by 
morphology and flow cytometry. NET formation was 
determined by fluorescent microscopy and DNA release 
assays. NET interaction with macrophages was examined 
by measuring cytokine generation with ELISA and qRT-
PCR.
results CF neutrophils live longer due to decreased 
apoptosis. This was observed in both cystic fibrosis 
transmembrane conductance regulator (CFTR) null 
piglets and patients with CF, and furthermore was 
reversed by ivacaftor (CFTR potentiator) in patients with 
gating (G551D) mutations. CF neutrophils formed more 
NETs and this was reversed by cyclin-dependent kinase 
inhibitor exposure. NETs provided a proinflammatory 
stimulus to macrophages, which was enhanced in CF.
conclusions CF neutrophils have a prosurvival 
phenotype that is associated with an absence of 
CFTR function and allows increased NET production, 
which can in turn induce inflammation. Augmenting 
neutrophil apoptosis in CF may allow more appropriate 
neutrophil disposal, decreasing NET formation and thus 
inflammation.
IntroductIon
Cystic fibrosis (CF) is the most common fatal single 
gene disorder in Caucasian populations with a prev-
alence of 1 in 2000 live births, and is a multiorgan 
disease affecting the lungs, pancreas, sweat glands, 
gut, liver and kidney. The inflammatory response to 
infection with lower respiratory pathogens in CF 
is exaggerated with most patients dying from lung 
disease.1 The pathophysiology of CF lung disease 
is poorly understood but significant factors include 
impaired bacterial killing, decreased mucus clear-
ance and overexuberant inflammation.2 Neutro-
phils are a key inflammatory cell in the CF lung 
acting as professional phagocytes, but their interac-
tion with other immune cells in the lung may be as 
important and requires further investigation.
The ability of neutrophils to undergo spon-
taneous apoptosis is protective to the host and is 
central to the resolution of infectious or inflam-
matory insults.3 Several studies have demonstrated 
defects in apoptosis leading to increased neutro-
phil survival in CF,4 5 but the consequences of this 
remain unclear. In the absence of spontaneous 
apoptosis, other mechanisms of neutrophil disposal 
such as neutrophil extracellular trap (NET) forma-
tion (NETosis) may become increasingly important. 
NETosis has been proposed as an additional mech-
anism by which neutrophils can kill bacteria, 
functioning in addition to phagosomal killing.6 7 
NETosis occurs in stimulated neutrophils (eg, by 
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Key messages
What is the key question? 
 ► Do cystic fibrosis (CF) neutrophils live 
longer and allow the preferential formation 
of neutrophil extracellular traps (NET)?
What is the bottom line? 
 ► CF neutrophils have a primary defect causing 
decreased spontaneous apoptosis and allowing 
increased levels of NET formation that can 
promote inflammation.
Why read on? 
 ► This work links a fundamental cystic fibrosis 
transmembrane conductance regulator-
related defect in neutrophil apoptosis to the 
promotion of inflammation in CF by NETs, and 
demonstrates that augmenting neutrophil 
apoptosis may be a therapeutic strategy to 
reduce NET formation and inflammation in CF.
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interleukin (IL)-8, lipopolysaccharide (LPS), phorbol myristate 
acetate (PMA) or bacteria) which undergo an oxidative burst and 
emit a network of DNA, histones, antibacterial and potentially 
proinflammatory proteins. An excess of NETs has been described 
in the CF airway,8 9 which could be due to either increased 
production or decreased clearance from the CF lung. NETs 
have also been associated with inflammatory conditions such as 
arthritis, systemic lupus erythematosus (SLE) and gout,10–12 and 
more recently NETs have been shown to interact with macro-
phages and prime inflammation in vascular disease.13 Therefore, 
the interaction of NETs with macrophages as a driver of inflam-
mation could be particularly relevant in CF, where macrophages 
have an overexaggerated response to inflammatory stimuli.14
We hypothesised that neutrophil survival is constitutively 
increased in CF due to decreased apoptosis, allowing more 
neutrophils to form NETs that will interact with macrophages 
and promote inflammation.
Methods
collection of samples from patients with cF
Peripheral blood was collected from stable patients with CF 
attending the Scottish National CF Service. Patients were consid-
ered stable if they had not required intravenous antibiotics in the 
past 2 weeks. Lung transplant patients were excluded. Patients 
gave written consent and the study was approved by regional 
ethics committees (East of Scotland Research Ethics Committee, 
15/ES/0094, West of Scotland Research Ethics Committee, 11/
WS/0074). Anonymous matched healthy controls were recruited 
locally (Lothian Research Ethics Committee, 08/S1103/38). 
Sample collection from patients before and after ivacaftor 
therapy was approved by the St Vincent’s University Hospital, 
Dublin, Research and Ethics Committee.
Isolation of human neutrophils and peripheral blood 
mononuclear cells
Human peripheral blood was collected into 3.8% sodium citrate. 
Plasma was aspirated following centrifugation of whole blood 
at 350×g for 20 min. Polymorphonuclear cells and peripheral 
blood mononuclear cells (PBMC) were isolated by 6% dextran 
sedimentation and separated by discontinuous (72.9, 63.0% and 
49.5%) Percoll (GE Healthcare, Buckinghamshire, UK) gradient 
as described.15 Isolated cells were washed twice in cation-free 
Dulbecco’s phosphate buffered saline (DPBS-/-) and then resus-
pended in appropriate culture media. In some experiments 
(referred to in the Results section), neutrophils were isolated 
using Ficoll-Paque (GE Healthcare) dextran sedimentation and 
hypotonic lysis of residual erythrocytes.
cell viability and apoptosis measurement
Isolated neutrophils (5×106/mL) were cultured in 24 or 96-well 
plates in Iscove’s Modified Dulbecco’s Medium (IMDM) (in 
some experiments Roswell Park Memorial Medium (RPMI) was 
substituted) supplemented with 5% autologous serum (in some 
experiments 10% fetal calf serum (FCS) or no serum was substi-
tuted), 1% penicillin and streptomycin, and 1% L-glutamine 
alone or in the presence of AT7519 (Astex Pharmaceuticals, 
Cambridge, UK), granulocyte-macrophage colony-stimulating 
factor (GM-CSF; R&D Systems, Abingdon, UK) or E. coli LPS 
(Sigma, Dorset, UK) for 24 hours at 37°C, 5% CO2. At stated 
time points, neutrophils were resuspended (1:5) in DPBS-/- 
supplemented with 25 mM calcium chloride and labelled with 
Annexin V-FLUOS (Sigma) at 1:500 and 1 µg/mL propidium 
iodide (PI) before analysis on a BD FACS Scan, FACS Calibur 
or BD Accuri cell analyzer as described.16 Cytocentrifuge prepa-
rations were stained with Diff-Quick (Gamidor, Didcot, UK) to 
assess for morphological changes of apoptosis.
Western blotting
Western blotting was carried out as previously described,17 with 
the following antibodies: Mcl-1 (1:1000; Santa Cruz, Dallas, 
TX, USA), BAX (1:1000; Santa Cruz), β-actin (1:50 000; Sigma) 
and horseradish peroxidase-conjugated secondary antibodies 
(1:2500; Dako, Cambridgeshire, UK).
Microscopic detection of nets
Neutrophils were seeded (5×104/well) into 24-well plates in 
RPMI with 5% FCS, allowed to adhere for 30 min and then 
stimulated with 10 nM PMA and incubated for 4 hours at 37°C, 
5% CO2. In some experiments, they were allowed to adhere 
for 6 hours in the presence of media alone or media with 
1 µM AT7519 and/or 2.5 ng/mL GM-CSF prior to stimulation 
and further incubation for 4 hours. After the incubation time, 
0.15 µM SYTOX green (Invitrogen, Thermo Scientific, UK) was 
added before bright field and fluorescent (470/22 nm light emit-
ting diodes excitation) images were captured on an EVOS FL cell 
imaging system. NET formation was quantified as percentage 
of SYTOX positive NETs per 10× field (NETs % of total cell 
count on bright field), as described.15 18 All samples were plated 
in duplicate and multiple fields were counted per well.
net dnA release kinetic assay
This was based on a published assay.15 19 Isolated neutrophils 
were seeded (5×104/well) in RPMI 1640 media supplemented 
with 5% FCS into a flat-bottom 96-well plate and allowed to 
adhere for 30 min at 37°C, 5% CO2. NETs were induced by 
addition of 10 nM PMA and detected at 30 min intervals in a 
Synergy HT BioTek plate reader by addition of 0.15 µM SYTOX 
green, a cell permeable nucleic acid stain with excitation/emis-
sion spectra of 504/523 nm. In some experiments, 1 µM AT7519 
and/or 25 ng/mL GM-CSF were added to the culture media for 
6 hours prior to PMA stimulation.
human macrophage culture
Isolated PBMCs were seeded in IMDM into 6-well plates for 
60 min (Nunc Upcell, ThermoFisher, Waltham, MA). Media was 
then removed, cells were washed twice in IMDM and remaining 
adherent monocytes were cultured in IMDM supplemented with 
10% autologous serum, 1% penicillin and streptomycin, and 
1% L-glutamine for 5 days at 37°C, 5% CO2. On day 5, cells 
were washed twice in DPBS-/- before detachment. Monocyte-de-
rived macrophages (MDM) were then seeded into 48-well tissue 
culture plates at 2.5×105/well into IMDM supplemented with 
10% autologous serum, 1% penicillin and streptomycin, and 1% 
L-glutamine for a further 1–2 days at 37°C, 5% CO2.
human nets and macrophage coculture
Isolated neutrophils were stimulated with 100 nM PMA or 
dimethyl sulfoxide vehicle control in Hanks' balanced salt solu-
tion (HBSS-/-) for 15 min in rolling suspension at room tempera-
ture (to stop clumping). Neutrophils were then washed three 
times in HBSS-/- to remove any residual PMA before seeding 
5×105/well onto MDMs (2:1 neutrophil to MDM ratio) in 
500 µL IMDM supplemented with 10% macrophage-donor 
serum, 1% penicillin and streptomycin, and 1% L-glutamine 
for 24 hours at 37°C, 5% CO2. PMA-treated neutrophils were 
considered NETing neutrophils (or NETs) and non-PMA-treated 
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neutrophils as control neutrophils. Supernatants were collected 
at 24 hours, centrifuged at 300×g for 5 min to remove cell 
debris and frozen at −80°C. RNA was extracted from remaining 
adherent MDMs using the Direct-Zol RNA extraction kit per 
manufacturer’s instructions (Zymo Research, Irvine, CA).
coculture supernatant eLIsA
IL-8 and tumour necrosis factor (TNF) were measured in culture 
supernatant using commercially available ELISAs (R&D Systems) 
as per the manufacturer’s instructions.
qRT-PCR of macrophage gene qRT-PCR was performed using 
commercially available TaqMan gene expression assays (Ther-
moFisher) for IL8, TNF, CXCL9, CCL17 and 18s RNA as per 
manufacturer’s instructions. Data were expressed as fold change 
from control.
scanning electron microscopy of bronchial tissue
Bronchial tissue was obtained from an explanted CF lung (under 
institutional board approval, University of Iowa) and fixed with 
2.5% glutaraldehyde in 0.1 M cacodylate buffer and processed 
for electron microscopy (EM). For full methods, see online 
supplementary data.
statistical analysis
All data are expressed as mean±SE error of the mean. Flow 
cytometry data were analysed using FlowJo software (TreeStar, 
Ashland, Oregon) or BD Accuri platform specific software. Data 
were analysed with GraphPad Prism (La Jolla, CA) by t-test, 
Mann-Whitey U test or analysis of variance with appropriate 
post-test as noted in figures.
resuLts
cF neutrophils have increased survival due to less apoptosis
CF neutrophils displayed increased survival when assessed 
by morphology on cytocentrifuge preparations (figure 1A–C, 
p<0.001). We confirmed this using flow cytometry by Annexin 
V and PI staining. Control neutrophils displayed more completed 
apoptosis at 24 hours than CF neutrophils, (figure 1D,E, 
p<0.01), and at 24 hours more neutrophils were viable in the 
CF samples suggesting a prosurvival phenotype secondary to 
a decrease in apoptosis (figure 1F, p=0.0004). Pan-caspase 
inhibition effectively inhibited all cell death in CF neutrophils 
(figure 1G, p<0.001) confirming that apoptosis is the major 
mechanism of neutrophil death in CF but is delayed in compar-
ison to healthy controls.
delayed neutrophil apoptosis in cF is related to a 
loss of cystic fibrosis transmembrane conductance 
regulator function
Next we assessed whether the delayed apoptosis in CF was related 
to decreased cystic fibrosis transmembrane conductance regulator 
(CFTR) function in neutrophils. We obtained neutrophils (using 
Ficoll-Paque and red cell lysis) from 12 patients with at least one 
G551D mutation prior to and 2 days after commencing ivacaftor 
therapy (150 mg twice daily), a CFTR potentiator drug which 
increases conductance of abnormal CFTR and has a proven clin-
ical effect.20 The samples were obtained as part of a previously 
published observational study,21 22 but prepared and analysed 
separately of the other work. Neutrophil survival at 24 hours 
was significantly decreased after ivacaftor therapy, suggesting 
that CFTR potentiation reverses the prosurvival phenotype in 
CF neutrophils (figure 2A–C, p=0.014). This effect was also 
seen when patients had treatment for 7 days (data available for 
six patients, online supplementary figure S1, p=0.0313). To 
ensure that the apoptosis inducing effects of ivacaftor were not a 
non-specific effect of the drug, we tested the ability of Ivacaftor 
to induce neutrophil apoptosis in healthy control neutrophils in 
culture. No effect was demonstrated after 20 hours of in vitro 
culture over a range of doses (online supplementary figure S2).
Next we investigated whether the neutrophil survival pheno-
type was related to the absence of CFTR in neutrophils by util-
ising CFTR null neutrophils from CFTR-/- piglets (CF piglets). 
Neutrophils were harvested (using Ficoll-Paque and red cell 
lysis) from 2-week-old CF piglets and wild-type controls 
and cultured ex vivo in the presence of 10% FCS. CF piglet 
neutrophils demonstrated prolonged survival, suggesting that 
increased neutrophil survival (due to decreased apoptosis) is a 
primary defect related to absence of CFTR from neutrophils 
(figure 2D,E, p=0.027).
Prolonged cF neutrophil lifespan is not caused by 
inflammation
Inflammation has been suggested to prolong neutrophil lifespan 
by inducing changes in the expression of Bcl-2 family members, 
in particular Mcl-123 and BAX.5 Using samples from patients 
with CF, we demonstrated no difference in the expression of 
Mcl-1 and BAX between CF neutrophils and healthy controls 
(figure 3A–C), suggesting that inflammation-induced dysregula-
tion of intrinsic apoptosis-regulating proteins was not the cause 
of the prolonged survival of CF neutrophils. Furthermore, the 
addition of prosurvival stimuli GM-CSF or LPS to CF neutro-
phils augmented the prosurvival phenotype, demonstrating that 
activating factors could further enhance the increased neutro-
phil survival in CF (figure 3D, p<0.001), rather than being 
the underlying mechanism. To assess whether a serum factor 
related to the inflammatory environment did not cause the 
apoptosis delay, we cultured healthy control neutrophils in the 
presence of CF serum. The addition of 5% pooled CF serum to 
healthy neutrophil cultures did not increase neutrophil survival 
(figure 3E). Next we asked whether we could therapeutically 
reverse the apoptosis delay in CF neutrophils. Culture of CF 
neutrophils in the presence of AT5719, a cyclin-dependent 
kinase (CDK) inhibitor (CDKi) known to induce neutrophil 
apoptosis,17 significantly induced apoptosis in control (p<0.01), 
and CF neutrophils (p<0.001), effectively correcting the apop-
tosis delay in CF to that of control levels (figure 3F).
cF neutrophils form more nets than healthy controls due to 
their prosurvival phenotype
As CF neutrophils were characterised by reduced apoptosis, we 
then asked whether they were consequently more susceptible to 
NETosis. Freshly isolated human CF neutrophils formed NETs 
as efficiently as healthy control neutrophils in response to 10 nm 
PMA (figure 4A) after 4 hours of culture. This was confirmed 
by assessing NET formation by DNA release assay (figure 4B,E). 
However, DNA release from CF neutrophils diverged from 
control neutrophil DNA release at 6 hours, suggesting that CF 
neutrophils formed more NETs than non-CF controls as they 
aged in culture, and failed to engage in apoptosis (figure 4B). 
We therefore assessed whether aged CF neutrophils could form 
more NETs than aged non-CF control neutrophils. Neutrophils 
were aged for 6 hours and then stimulated with 10 nM PMA to 
induce NETs. CF neutrophils formed significantly more NETs 
than similarly aged non-CF control neutrophils (figure 4C, 
p=0.0087, and figure 4D, p<0.001). We then assessed whether 
either adding prosurvival factors to control neutrophils would 
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Figure 1 CF neutrophils have increased survival due to less apoptosis. (A) Cultured CF neutrophils are more viable at 24 hours than healthy controls 
when assessed by morphology (n=6 CF, 5 controls). (B) Freshly isolated viable neutrophils in ex vivo culture demonstrating multilobed nuclei (×100 
objective). (C) Apoptotic neutrophils following prolonged ex vivo culture demonstrating characteristic nuclear condensation (×100 objective). (D) Flow 
plot of control neutrophils at 24 hours ex vivo culture demonstrating small numbers of viable cells (V=annexin V−ve/PI−ve cells) with the majority 
of cells having entered apoptosis (A=annexin V+ve/PI−ve) or completed apoptosis (CA=annexin V+ve/PI+ve). (E) Control neutrophils have a higher 
rate of completed apoptosis than CF (n=19 CF and 20 controls, for patient details see online supplementary table E1). (F) More viable neutrophils 
are present in CF culture at 24 hours (n=19 CF and 20 controls). (G) Addition of the pan-caspase inhibitor Q-VD-OPh hydrate to CF neutrophil culture 
increases survival by inhibiting constitutive apoptosis. For patient details, see online supplementary table E1. Data presented as mean±SEM. Analysis 
with two-way analysis of variance and Bonferroni (A, E, G), unpaired t-test (F). **p<0.01; ***p<0.001. CF, cystic fibrosis; PI, propidium iodide; QVD, 
Q-VD-OPh hydrate.
cystic fibrosis
enhance NET formation, or inducing early apoptosis in CF 
neutrophils would reduce NET formation. The addition of the 
GM-CSF to non-CF control neutrophils for 6 hours prior to 
PMA stimulation increased NET formation (figure 5A, p<0.01). 
Conversely, NET formation in CF neutrophils was inhibited by 
CDKi (figure 5A,B, p<0.001).
nets stimulate an inflammatory response from macrophages 
and this is exaggerated in cF
We used scanning EM to demonstrate the presence of NETs 
in the lungs of a patient with CF undergoing lung transplan-
tation (figure 6A) based on morphology and features similar 
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Figure 2 Delayed neutrophil apoptosis in CF is related to a loss of cystic fibrosis transmembrane conductance regulator (CFTR) function. Neutrophils 
were harvested from 12 patients with at least one G551D mutation before and after starting the CFTR potentiator ivacaftor (for patient details, 
see online supplementary table E2), and cultured ex vivo for 24 hours. (A) and (B) demonstrate example flow plots (following 24 hours ex vivo culture) 
from an individual patient before (A) and 2 days after (B) starting ivacaftor, showing that neutrophil survival decreased with treatment. (C) Combined 
data for 12 patients receiving ivacaftor, neutrophil viability decreased significantly with treatment. (D) Neutrophils were harvested from 2-week-old 
CF piglets and wild-type (WT) controls. Flow cytometry following 24 hours ex vivo culture demonstrated increased survival in CF (5 CF pigs and 5 
WT controls). (E) Representative cytocentrifuge preparations of CF and WT neutrophils at 0 and 24 hours (×100 objective) demonstrating increased 
numbers of apoptotic neutrophils in WTs at 24 hours. Data presented as mean±SEM. Analysis with paired t-test (C), Mann-Whitney U test (D). 
*p<0.05. CF, cystic fibrosis; PI, propidium iodide.
cystic fibrosis
to previous descriptions of NETs on EM.9 Next we developed 
a technique to enable the coculture of NETs (NETing neutro-
phils) and MDMs at consistent ratios by stimulating neutrophils 
with 100 nM PMA under rolling conditions, washing and then 
adding them to MDMs where they then form NETs demon-
strating classic morphology after 4–6 hours (online supple-
mentary figure S3). Supernatants and RNA were harvested 
from cocultures at 24 hours (figure 6B). The addition of NETs 
to healthy volunteer MDMs induced IL-8 and TNF produc-
tion (figure 6C,D, p<0.01 and p<0.05, respectively). This 
effect was also observed when NETs were added to CF MDMs 
(figure 6C,D, p<0.001 both). The IL-8 and TNF response to 
NETs was exaggerated in CF MDMs compared with healthy 
volunteers (figure 6C,D, p<0.05 and p<0.001, respectively). 
qRT-PCR confirmed increased IL-8 and TNF expression (not 
shown), and demonstrated that NETs induced the expression of 
CCL17, a marker of alternative activation in macrophages,24 in 
both CF and control MDMs (figure 6E, p<0.001). Of note, CF 
MDMs had increased basal expression of the classical macro-
phage activation marker CXCL9 (figure 6F, p<0.001),25 which 
was further augmented by NETs (although without statis-
tical significance). Overall, these data suggest that CF MDMs 
interacting with NETs have phenotypic markers of both classical 
and alternative activation.
dIscussIon
Our data demonstrate that CF neutrophils survive longer due 
to delayed apoptosis and this is associated with the absence of 
CFTR function. Furthermore, this delay in apoptosis allows CF 
neutrophils to form NETs more efficiently than healthy control 
neutrophils, which may be an important proinflammatory 
mechanism. Impairment of neutrophil apoptosis in CF has been 
reported,4 5 26 and previous studies have suggested that this is 
either a response to systemic inflammation5 or, alternatively, a 
specific defect in CF neutrophils.4 26 The reversal of the apoptosis 
delay in patients with CF treated with (the CFTR potentiator) 
ivacaftor suggests that CFTR function in neutrophils is asso-
ciated with apoptosis pathways. Indeed, previous studies have 
demonstrated direct effects of CFTR potentiation with ivacaftor 
on neutrophils,27 28 suggesting a fundamental role for CFTR in 
a number of neutrophil functions, consistent with CFTR being 
expressed at a biologically significant level.29 Our observation 
that apoptosis is impaired in neutrophils from CFTR null piglets 
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Figure 3 Prolonged CF neutrophil lifespan is not caused by inflammation. CF neutrophils have normal baseline apoptotic signalling of (A) Mcl-1, a 
37 kDa antiapoptotic protein, and (B) BAX, a 21 kDa proapoptotic protein when freshly isolated (n=8 CF and 8 healthy controls, for patient details see 
online supplementary table E3). (C) Mcl-1 and BAX densitometry. (D) CF neutrophils retain sensitivity to delayed apoptosis with prosurvival stimuli 
GM-CSF (20 ng/mL) and LPS (10 ng/mL) for 24 hours (n=19 CF and 20 controls, for patient details see online supplementary table E1). (E) The primary 
apoptosis defect in CF is not due to a circulating CF serum factor. Healthy control neutrophils were cultured in media containing 5% pooled CF 
serum and this did not lead to increased neutrophil survival (n=3 separate healthy donors). (F) The survival defect in CF could be corrected by culture 
with AT7519 (1 µM) for 24 hours to augment neutrophil apoptosis and effectively reduce survival to healthy control levels (n=19 CF and 20 controls, 
for patient details see online supplementary table E1). Data presented as mean±SEM. Analysis with unpaired t-test (C), one-way analysis of variance 
with Newman-Keuls post-test (D, F). *p<0.05; **p<0.01; ***p<0.001. CF, cystic fibrosis; GMCSF, granulocyte-macrophage colony-stimulating factor; 
LPS, lipopolysaccharides; PI, propidium iodide.
cystic fibrosis
underlines the potential primary nature of delayed neutrophil 
apoptosis in CF. CFTR has been demonstrated to have a func-
tional role in phagolysosomal activity in both macrophages30 
and neutrophils,31 32 and the absence of CFTR promotes inflam-
matory cytokine release from macrophages.14 33 CFTR has 
also been implicated in the regulation of T cell suppression by 
myeloid suppressor cells34 and, as such, a diverse but functional 
role of CFTR in myeloid cells has now been established.
Our data demonstrate that the prolonged survival of CF 
neutrophils cannot entirely be explained by inflammation in 
CF. The Bcl-2 family pro and antiapoptotic proteins BAX and 
McL-1 have been implicated in inflammation-induced neutro-
phil survival. Mcl-1 excess is observed in neutrophils from 
patients with sepsis leading to prolonged neutrophil survival,23 
but we demonstrated no difference in expression between CF 
and healthy control neutrophils. Inflammation-induced BAX 
deficiency has been suggested as a cause of delayed neutrophil 
apoptosis in CF and pneumonia,5 but again there was no differ-
ence in expression between CF and healthy control neutro-
phils. Our data infer that the apoptosis delay in CF is a primary 
feature of CF neutrophils and not simply related to inflamma-
tion, further emphasised by CF serum failing to prolong survival 
in healthy control neutrophils. Exposure of CF neutrophils to 
prosurvival stimuli such as GM-CSF or LPS further enhances 
survival, which may be particularly relevant once neutrophils 
have reached the inflammatory environment of the CF lung. 
The CF lung environment has been shown to induce changes in 
neutrophil behaviour and phenotype,35 36 and is therefore likely 
to accentuate the prosurvival phenotype that we demonstrate 
in CF.
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Figure 4 CF neutrophils form more NETs than healthy controls under conditions of ageing in culture. (A) Freshly isolated CF neutrophils form similar 
amounts of NETs as healthy controls (11 CF vs 6 controls, for patient details see online supplementary table E3) following stimulation with 10 nM 
phorbol myristate acetate (PMA). (B) DNA release as surrogate marker of NET production yielded similar results from PMA-treated freshly isolated 
neutrophils (7 CF vs 6 controls), although we observed a non-statistically significant increase in DNA release at later time points by CF neutrophils. 
(C) Neutrophils aged in culture for 6 hours prior to stimulation with PMA (10 nM) demonstrated increased NET production by CF neutrophils versus 
controls (n=6 CF vs 6 controls). (D) Increased NET production in aged neutrophils was confirmed by DNA release assay (n=6 CF vs 6 controls). (E) 
Representative fluorescent microscopy following addition of SYTOX green in non-fixed cells, demonstrating increased PMA-induced NETs in CF 
following neutrophil ageing compared with controls (and also non-aged CF). Both diffuse morphology and spread morphology NETs are seen (scale 
bar=10 µm). Data presented as mean±SEM. Analysis with unpaired t-test (A, C), two-way analysis of variance with Bonferroni (D). **p<0.01; 
***p<0.001. CF, cystic fibrosis; NET, neutrophil extracellular trap; OD, optical density.
cystic fibrosis
We restored CF neutrophil apoptosis to healthy control levels 
by using the CDKi AT7519, a strategy that has been demon-
strated to decrease inflammation in sterile and infective models 
of inflammation.17 37 Apoptosis is a well-described route of 
disposal for potentially toxic and damaging neutrophils and 
the phagocytosis of these apoptotic cells drives inflammation 
resolution.3 Targeting neutrophil apoptosis as an anti-inflam-
matory strategy in CF is therefore attractive, as it would offer 
group.bmj.com on September 19, 2017 - Published by http://thorax.bmj.com/Downloaded from 
8 Gray RD, et al. Thorax 2017;0:1–11. doi:10.1136/thoraxjnl-2017-210134
Figure 5 CF neutrophils form more NETs due to their prosurvival phenotype. (A) Healthy control and CF neutrophils were cultured for 6 hours in the 
presence of GM-CSF (2.5 ng/mL)±AT7519 (1 µM) and then stimulated with PMA (10 nM). The addition of GM-CSF to control neutrophils increased NET 
formation to that of CF levels. This effect was reversed by AT7519, suggesting that inducing apoptosis stopped NET formation (n=6 CF and 6 healthy 
controls). (B) Representative fluorescent microscopic images showing SYTOX positive diffuse NETs in culture, enhanced by GM-CSF and inhibited by 
AT7519 in a patient with CF (scale bar=10 µm). Data presented as mean±SEM. Analysis with one-way analysis of variance with Newman-Keuls post-
test (A). **p<0.01; ***p<0.001. CF, cystic fibrosis; GMCSF, granulocyte-macrophage colony-stimulating factor; NET, neutrophil extracellular trap; 
PMA, phorbol myristate acetate; AT, AT7519.
cystic fibrosis
a universal therapy not dependent on a patient’s individual CF 
genotype. Furthermore, engaging CF neutrophils in apoptosis 
more effectively may avoid more toxic forms of cell disposal 
such as NETosis.
We demonstrate for the first time that CF neutrophils form 
more NETs than healthy controls. Several lines of evidence high-
light the importance of NETosis in CF. Excess amounts of DNA 
in the CF airway have been regarded as a potential contributor 
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Figure 6 NETs stimulate an inflammatory response from macrophages and this is exaggerated in CF. (A) Scanning electron microscopy of bronchus 
from patient with explanted CF lung showing characteristic strands of NET-like material associated with neutrophils and bacteria. (B) Outline of novel 
NET/MDM coculture system. (C) NETs are proinflammatory to MDMs, causing an increase in IL-8 production after 24 hours of coculture and this effect 
is more pronounced with CF MDMs (n=8 CF and 7 healthy MDM donors, for patient details see online supplementary table E3). (D) NETs induce TNF 
production from MDMs. (E) NETs induce CCL17 expression in healthy and CF MDMs. (F) NETs induce a non-significant increase in CXCL-9 expression 
in healthy controls, whereas CXCL-9 is overexpressed at baseline in CF. Data presented as mean±SEM. Analysis by one-way analysis of variance with 
Newman-Keuls post-test (C–F). **p<0.01; ***p<0.001. CCL, chemokine (C-C motif) ligand; CF, cystic fibrosis; CXCL, chemokine (C-X-C motif) ligand; 
IL, interleukin; MDM, monocyte-derived macrophage; NET, neutrophil extracellular trap; PMA, phorbol myristate acetate; TNF, tumour necrosis factor; 
WT, wild type.
cystic fibrosis
to lung disease since the 1960s, although the presence of DNA in 
the form of NETs is a more recent finding.8 9 38 39 These studies, 
however, fail to definitively address whether CF neutrophils 
form more NETs than healthy control cells. Our data demon-
strate that CF neutrophils form more NETs than controls and 
this is directly related to the reduction in CF neutrophil apop-
tosis. The evidence for this is severalfold. First, the major differ-
ence in NET formation is observed when neutrophils are aged 
prior to PMA stimulation by which time control neutrophils, 
although viable, will have engaged early apoptotic machinery. 
Second, if non-CF neutrophils are cultured in the presence of 
GM-CSF before PMA stimulation (to delay apoptosis), they 
form equivalent numbers of NETs to CF neutrophils. And finally, 
culture of CF neutrophils for 6 hours in the presence of CDKi 
before PMA stimulation reduces the level of NET formation 
in CF to that of healthy controls. Taken together, these data 
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suggest that CF neutrophils form more NETs because they are 
less able to engage in the normal process of apoptosis, but this 
can be reversed by augmenting apoptosis with CDKi, in keeping 
with other studies suggesting that the engagement of several 
non-apoptotic pathways is required for NET formation.40–42 
These data also suggest that CDKi may offer a viable thera-
peutic strategy to subvert NETosis in CF and drive cells towards 
apoptosis and thus promote inflammation resolution. CDKs are 
present in a number of isoforms and have a diverse role in cell 
behaviour, although the major isoforms involved in the regula-
tion of neutrophil apoptosis are CDKs 7 and 9.43 44 CDKi may 
also affect other kinases, for example, glycogen synthase kinase 
3 (GSK-3), and in particular the GSK-3β isoform.45 Although 
it is worth noting that GSK-3α is the major isoform found in 
neutrophils,46 this off-target effect may be less important in the 
context of the present work. Further study of the role of CDKs 7 
and 9 in CF neutrophil apoptosis and NETosis will therefore be 
essential in our understanding of these processes.
There has been recent acknowledgement that granulocyte 
populations may display a degree of phenotypic heterogeneity 
leading to the description of low-density neutrophils (LDNs).47 
Interestingly, a subclass of LDNs, low-density granulocytes 
(LDGs) may form greater numbers of NETs than ‘normal’ gran-
ulocytes in SLE,48 although the opposite findings have been 
described in the study of NETosis in rheumatoid arthritis.49 We 
did not investigate the role of LDNs in the present study, but 
the contribution of LDNs/LDGs to NET formation in CF would 
merit further investigation going forward.
We demonstrate that NETs are a potent proinflammatory 
signal to macrophages. The ability of NETs to kill bacteria has 
been described since their first description in 2004,6 but the 
potential inflammatory consequences of the presence of NETs in 
CF have not. We developed an assay to assess whether NETing 
neutrophils cultured at a consistent ratio with macrophages could 
promote the release of proinflammatory cytokines (from macro-
phages), and whether CF macrophages were more susceptible to 
this stimulus. NETs induced IL-8 and TNF release from MDMs 
in contrast to previous data.50 Our data are however consistent 
with the recent finding that NETs can prime macrophages for 
further cytokine release.13 We demonstrated an enhanced cyto-
kine release from CF MDMs in response to NETs, consistent 
with CF macrophages being hyper-responsive to proinflam-
matory stimuli.14 We also demonstrate that the interaction of 
NETs with CF MDMs is associated with the expression of both 
classical and alternative markers of macrophage activation and 
would speculate that this could be a contributing factor to the 
non-resolving (frustrated) inflammation in CF. Although not 
addressed in this study, CF epithelial cells are a central part of 
the innate immune system in CF and as such the interaction of 
NETs with epithelial cells is of significant interest and will be 
subject to future study.
We acknowledge a number of limitations in this present study. 
First, we used peripheral blood neutrophils to study apoptosis 
and NETosis in the context of CF. Airway neutrophils may have 
a distinct phenotype in CF,35 36 and as such further study of the 
processes described in this paper (in airway neutrophils) may be 
indicated. Nevertheless, peripheral neutrophils have been used 
previously to assess neutrophil function,4 27 29 51 underlining the 
validity of this approach. Second, we obtained neutrophils from 
CF adults with established lung disease and therefore established 
lung inflammation. An effect of inflammation on neutrophil 
death pathways in CF can therefore not be completely excluded 
by our data, although our data would suggest the mechanism 
is inflammation independent (particularly when we consider 
the results from CFTR-/- piglets). Further investigation of these 
processes in neutrophils from children with CF before and 
after the onset of significant inflammatory lung disease would 
help address this in the future. Third, although we suggest an 
association of CFTR deficiency with delayed apoptosis that is 
corrected by ivacaftor therapy in patients with the G551D muta-
tion, further studies of CFTR potentiation and correction and 
its effects on neutrophil processes such as apoptosis and NETosis 
will be required. The advent of newer combination therapies to 
correct and potentiate the more common CF mutations such 
as F508del will make this possible in the future,52 allowing the 
study of both in vivo and in vitro correction of CFTR on neutro-
phil functions. Furthermore, we would suggest that the CFTR 
null pig may also be used to investigate neutrophil function and 
death related to CFTR deficiency, as an extension of our data in 
this paper and as recently studied in CF pig macrophages.33
In summary, we demonstrate that CF neutrophils have 
prolonged survival secondary to decreased apoptosis, and this 
is likely a primary defect in CF neutrophils. Increased NET 
formation by CF neutrophils is a consequence of a failure to 
engage in apoptosis and can be targeted by CDKi drugs. NETs 
are a powerful proinflammatory stimulus to macrophages, with 
CF-derived macrophages being hyper-responsive to NET stimu-
lation. In conclusion, an intrinsic delay in neutrophil apoptosis 
enhances NET formation in CF and consequently inflammation, 
representing a novel target for the development of future anti-in-
flammatory therapies.
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